Evidence map›Paper›PMID 33538991›Full record

ArticleAging clinical and experimental research2021

Sarcopenia quality-of-life questionnaire (SarQoL)®: translation, cross-cultural adaptation and validation in Turkish.

Tugba Erdogan, Serdar Eris, Suna Avci, Meryem Merve Oren, Pinar Kucukdagli, Cihan Kilic, Charlotte Beaudart, Olivier Bruyere, Mehmet Akif Karan, Gulistan Bahat

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Aging clinical and experimental research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06143592 (The Effect of Inspiratory Muscle Training on Balance, Falls and Diaphragm Thickness in the Elderly), which is not on this map. Cited by 25 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06143592 naunknown statusnot on this mapstarted 2023, after this paper: background citation

The Effect of Inspiratory Muscle Training on Balance, Falls and Diaphragm Thickness in the Elderly: A Randomized Controlled Trial

TypeinterventionalSponsorGazi UniversityRan2023 to 2025Enrolled30ConditionsSarcopeniaArmsInspiratory Muscle Training
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Analysis of Structural Characteristics and Psychometric Properties of the SarQoLInternational journal of environmental research and public health · 2022
    Pooled it
  5. Trial
  6. Sarcopenia in atrial fibrillation: a prospective study.Turkish journal of medical sciences · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Validation of the German version of the SarQoLAging clinical and experimental research · 2024
    Article
  13. Article
  14. Article
  15. A leaky gut contributes to reduced sarcopenia-related quality of life (SarQoL) in geriatric older adults.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tugba ErdoganDivision of Geriatrics, Department of Internal Medicine, Istanbul Medical School, Istanbul University, Istanbul, Turkey.ORCID http://orcid.org/0000-0001-8690-0189
Serdar ErisDivision of Geriatrics, Department of Internal Medicine, Istanbul Medical School, Istanbul University, Istanbul, Turkey.
Suna AvciDivision of Geriatrics, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Meryem Merve OrenDepartment of Public Health Istanbul, Istanbul Medical School, Istanbul University, Istanbul, Turkey.
Pinar KucukdagliDivision of Geriatrics, Department of Internal Medicine, Istanbul Medical School, Istanbul University, Istanbul, Turkey.
Cihan KilicDivision of Geriatrics, Department of Internal Medicine, Istanbul Medical School, Istanbul University, Istanbul, Turkey.
Charlotte BeaudartPublic Health, Epidemiology and Health Economics, University of Liège, 4000, Liège, Belgium.
Olivier BruyerePublic Health, Epidemiology and Health Economics, University of Liège, 4000, Liège, Belgium.
Mehmet Akif KaranDivision of Geriatrics, Department of Internal Medicine, Istanbul Medical School, Istanbul University, Istanbul, Turkey.
Gulistan BahatDivision of Geriatrics, Department of Internal Medicine, Istanbul Medical School, Istanbul University, Istanbul, Turkey. gbahatozturk@yahoo.com.ORCID http://orcid.org/0000-0001-5343-9795

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe sarcopenia quality-of-life (SarQoL)® questionnaire is a multidimensional sarcopenia specific tool designed for community dwelling older adults.

aimsThe aim of this study was to translate, to cross-culturally adapt and validate the SarQoL® questionnaire to assess sarcopenia-related quality of life in Turkish older adults.

methodsThe validation process was performed in two sections: the first section constituted the translation with cross-cultural adaptation of SarQoL® into Turkish. Second section constituted the clinical validation study. To validate the Turkish version of the SarQoL®, we assessed its validity (discriminative power, construct validity), reliability (internal consistency, test-retest reliability) and floor/ceiling effects.

resultsOne hundred community-dwelling subjects (mean age: 74.7 ± 6.1 years) were evaluated. The EWGSOP2 consensus diagnostic criteria were used to diagnose probable sarcopenia. A database including 1437 older adults, with complete evaluation of sarcopenia parameters, served to define low global muscle function. Results revealed a good discriminative power: subjects with probable sarcopenia had higher total scores compared to non-sarcopenic subjects (50 ± 16 vs. 68.9 ± 16.9, p < 0.001) a high internal consistency (Cronbach's alpha: 0.88), consistent construct validity and excellent test-retest reliability (intraclass correlation coefficient: 0.97, 95% confidence interval: 0.94-0.98). There was no floor/ceiling effect.

conclusionThe Turkish version of the SaQoL® questionnaire was found to be reliable and valid for the measurement of quality of life of sarcopenic patients and is, therefore, available for use in clinical research and practice. This validation could enable use of the SarQoL® tool in the eastern populations more confidently.

Indexed as

Quality of LifeSarcopeniaAgedAged, 80 and overCross-Cultural ComparisonHumansPsychometricsReproducibility of ResultsSurveys and QuestionnairesQuality of lifeSarcopeniaSarQoLTranslationValidation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.